NRX Pharmaceuticals, Inc. Partners' Capital Account, Units, Sold in Private Placement
NRX Pharmaceuticals, Inc. (NRXP) reported Partners' Capital Account, Units, Sold in Private Placement of 3.59 million shares for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-21.
Discontinued › Partners' Capital Account, Units, Sale of Units
us-gaap:PartnersCapitalAccountUnitsSoldInPrivatePlacement · last filed 2021-05-21
- NRX Pharmaceuticals, Inc. partners' capital account, units, sold in private placement for the quarter ending 2021-03-31 was 3.59M shares.
| Period end | Partners' Capital Account, Units, Sold in Private Placement 3 month |
|---|---|
| 2021-03-31 | 3.59M shares 10-Q · filed 2021-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |